Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04320199 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Fermented Protaetia Brevitarsis Seulensis Powder on Alcohol-induced Liver Disease

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 4, 2025 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Dec 30, 2024 to Dec 30, 2025
    • Study completion date: Dec 31, 2024 to Dec 31, 2025
    v6
  2. Primary completion date: Dec 30, 2023 to Dec 30, 2024
    • Study completion date: Dec 31, 2023 to Dec 31, 2024
    v5
  3. Primary completion date: Dec 30, 2020 to Dec 30, 2023
    • Trial status: Completed to Recruiting
    • Study completion date: Dec 31, 2020 to Dec 31, 2023
    • Site details revised
    v4
  4. Trial status: Recruiting to Completed
    • Enrollment target: estimated 20 to confirmed 30
    • Site details revised
    v3
  5. Primary endpoint revised
    • Secondary endpoints revised (3)
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of Fermented Protaetia brevitarsis seulensis powder on Alcohol-induced Liver Disease in adults for 8 weeks.
Trial Details
NCT Number NCT04320199
Lead Sponsor Pusan National University Yangsan Hospital
Conditions
(from sponsor)		 Alcoholic Liver Disease
Related terms Liver Diseases, Alcoholic
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov